$JNJ

AI Analysis

Generated on May 18, 2026

AI Score
71/ 100
Hold$JNJ

Johnson & Johnson

$JNJNYSEHealthcareMega-Cap

Johnson & Johnson researches, develops, manufactures, and sells various products in the healthcare field worldwide.

Market Cap
$380B
Revenue (TTM)
$88.5B
+4.5%
Net Income (TTM)
$18.2B
+6.8%
EPS (TTM)
$7.58
P/E Ratio
21.2
Dividend Yield
3.0%
52-Week Range
$145-$172
Beta
0.52
Dimension Scores
Fundamental
76
Technical
65
Sentiment
70
Risk / Reward
74
Momentum
62
FundTechSentRiskMome
Financial Health
Profitability
80strong
Growth
62moderate
Liquidity
78moderate
Solvency
75moderate
Efficiency
78moderate

Valuation, technical analysis, investment thesis, risk assessment and more for $JNJ

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.